295 results
Page 9 of 15
8-K
EX-99.3
a3ocq5g
23 Apr 12
BioTime Provides Update on ReneviaTM Product Development
12:00am
8-K
EX-99.1
my6yu 1wxszmb046zn
23 Apr 12
BioTime Provides Update on ReneviaTM Product Development
12:00am
8-K
EX-99.1
drlb16ssagshmrsieb
23 Apr 12
BioTime Demonstrates Efficient Method for the Manufacture of Cartilage-Producing Cells from Human Embryonic Stem Cells
12:00am
8-K
EX-99.1
41i bo2hg2
20 Apr 12
Other Events
12:00am
8-K
EX-99.1
givrdjbc90 1h09i3
18 Apr 12
BioTime CEO Michael D. West to Present at the Future Leaders in the Biotech Industry Conference
12:00am
8-K
EX-99.1
wm3pgv 5g4z4v
16 Apr 12
BioTime CEO Michael D. West to Present at the 8th GTC Stem Cell Summit 2012
12:00am
8-K
EX-99.1
wil3lb06hilgha
12 Apr 12
Regulation FD Disclosure
12:00am
8-K
EX-99.1
08r aoeidtwhbobqg
22 Mar 12
BioTime’s Subsidiary OncoCyte Corporation Provides an Update on the Development of the Novel Pan-Cancer Diagnostic Product PanC-DxTM
12:00am
8-K
EX-99.1
lnap 9l7n
21 Mar 12
BioTime CEO Michael D. West to Present at 2012 Maxim Group Growth Conference
12:00am
8-K
EX-99.1
eldlunkh38fzerk
14 Mar 12
BioTime Announces Fourth Quarter and Fiscal Year End 2011 Financial Results and Recent Corporate Accomplishments
12:00am
8-K
EX-99.1
6itpiiwc
9 Mar 12
BioTime to Present at ROTH 24th Annual Growth Stock Conference
12:00am
8-K
EX-99.1
2rny392w
17 Feb 12
BioTime CEO Michael D. West to Present at New York Stem Cell Summit
12:00am
8-K
EX-99.1
5wga 9zxtl0
24 Jan 12
Other Events
12:00am
8-K
EX-99.1
xgh2olymbib2 go2a9
3 Jan 12
Other Events
12:00am
8-K
EX-99.1
lesn5uj ktoozya
21 Dec 11
BioTime Signs Agreement with USCN Life Science to Source Antibody-Based Products
12:00am
8-K
EX-99.1
jarbfig
16 Dec 11
BioTime’s Subsidiary OncoCyte Corporation Announces Plans for the Novel Pan-Cancer Diagnostic Product PanC-DxTM
12:00am
8-K
EX-99.1
vbhthn40a
12 Dec 11
BioTime Successfully Completes HyStem®-Rx Preclinical ISO 10993 Studies
12:00am
8-K
EX-99.1
0epjkmah
29 Nov 11
BioTime, Inc. Appoints Andrew C. von Eschenbach, M.D. to its Board of Directors
12:00am
8-K
EX-99.1
jn6fq zj7
8 Nov 11
BioTime Announces Third Quarter 2011 Financial Results and Recent Corporate Accomplishments
12:00am